It could be presumed that the stochastically distributed (in individual AD-affected neurons) rate of accumulation of iAβ produced in the AβPP-independent iAβ generation pathway in the second, symptomatic stage of AD and the extent of the T2 threshold are patient-specific and identical throughout the affected brain. This evidence concerns the gene APP and Alzheimer disease.